Human Genome Sciences, Inc. (HGSI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Human Genome Sciences, Inc. (HGSI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steven Rachbach who wrote (241)	12/29/1998 6:12:00 PM
From: David Bogdanoff	Read Replies (1) of 1127

SR: << I am sure the generation of new blood vessels in the heart would be of possible great therapeutic importance in the treatment of coronary artery disease as well. >> Does new coronary blood vessels qualify as peripheral vascular disease? Doesn't sound peripheral. I have seen a news item on tv for new coronary blood vessels but they didn't mention any companies. David

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next